What are the pharmacotherapeutic considerations for the treatment of myasthenia gravis?

被引：6
|
作者：
Vanoli, Fiammetta [1 ,2 ]
Mantegazza, Renato [1 ]
机构：
[1] Fdn IRCCS Ist Neurol Carlo Besta, Neuroimmunol & Neuromuscular Dis Dept, Milan, Italy
[2] Sapienza Univ Rome, Dept Human Neurosci, Rome, Italy
来源：
EXPERT OPINION ON PHARMACOTHERAPY | 2022年 / 23卷 / 13期
关键词：
Myasthenia gravis; monoclonal antibodies; immunosuppression; biological drugs; C5; FcRn; RITUXIMAB;
D O I：
10.1080/14656566.2022.2122710
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1471 / 1474
页数：4
相关论文
共 50 条
  • [31] What is the role of adipokines in myasthenia gravis?
    Rozmilowska, Izabela
    Czyzewski, Damian
    Mazur, Bogdan
    Adamczyk-Sowa, Monika
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2018, 14 : 1515 - 1525
  • [32] MYASTHENIA-GRAVIS - SYSTEMIC AND OCULAR CONSIDERATIONS
    MILLER, NR
    OPHTHALMOLOGY, 1979, 86 (12) : 2165 - 2174
  • [33] ANESTHETIC CONSIDERATIONS FOR MYASTHENIA-GRAVIS AND PREGNANCY
    ROLBIN, SH
    LEVINSON, G
    SHNIDER, SM
    WRIGHT, RG
    ANESTHESIA AND ANALGESIA, 1978, 57 (04): : 441 - 447
  • [34] Heterogeneity in myasthenia gravis: considerations for disease management
    Evoli, Amelia
    Spagni, Gregorio
    Monte, Gabriele
    Damato, Valentina
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2021, 17 (07) : 761 - 771
  • [35] What Is Your Diagnosis? Myasthenia gravis
    Schroeder, Mikayla M.
    Ober, Christopher P.
    Kiefer, Kristina
    Tom, Jasmine
    JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2016, 249 (09): : 1003 - 1005
  • [36] What are the treatment options for myasthenia gravis if first-line fail?
    Zust, Christopher
    Morren, John A.
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2023, 90 (02) : 81 - 84
  • [37] What Is the True Incidence and Prevalence of Myasthenia Gravis? A Systematic Review of Myasthenia Gravis Epidemiology
    Fitzpatrick, Aisling S.
    Cardwell, Chris
    McCarron, Peter
    McConville, John P.
    NEUROLOGY, 2009, 72 (11) : A467 - A467
  • [38] Cyclosporine in the treatment of myasthenia gravis
    Lavrnic, D
    Vujic, A
    Rakocevic-Stojanovic, V
    Stevic, Z
    Basta, I
    Pavlovic, S
    Trikic, R
    Apostolski, S
    ACTA NEUROLOGICA SCANDINAVICA, 2005, 111 (04): : 247 - 252
  • [39] Observations on the treatment of myasthenia gravis
    Cooke, AM
    Passmore, R
    QUARTERLY JOURNAL OF MEDICINE, 1936, 17 (05): : 21 - U5
  • [40] Myasthenia Gravis Treatment Updates
    CortOs-Vicente, Elena
    Gallardo, Eduard
    Elvarez-Velasco, Rodrigo
    Illa, Isabel
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2020, 22 (08)
12345